Scott Kirkley
Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Blood Transfusion | 8 | 1988 | 59 |
Why?
|
Blood Transfusion, Autologous | 6 | 1995 | 10 |
Why?
|
Health Plan Implementation | 2 | 2002 | 20 |
Why?
|
Leukocytes | 3 | 1994 | 94 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2002 | 7 |
Why?
|
Adjuvants, Immunologic | 2 | 1999 | 73 |
Why?
|
Coronary Artery Bypass | 1 | 2002 | 46 |
Why?
|
ABO Blood-Group System | 4 | 1994 | 26 |
Why?
|
Immunosuppression | 1 | 1999 | 47 |
Why?
|
Platelet Transfusion | 3 | 1994 | 20 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 1998 | 10 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 1998 | 19 |
Why?
|
Ovum | 1 | 1995 | 11 |
Why?
|
Cytokines | 2 | 1995 | 207 |
Why?
|
Blood Donors | 1 | 1994 | 19 |
Why?
|
Postoperative Complications | 3 | 2002 | 305 |
Why?
|
Blood Platelets | 1 | 1994 | 67 |
Why?
|
Leukapheresis | 1 | 2010 | 17 |
Why?
|
Acute Lung Injury | 1 | 2010 | 12 |
Why?
|
Vascular Diseases | 1 | 2010 | 60 |
Why?
|
Citrates | 1 | 1988 | 15 |
Why?
|
Th2 Cells | 2 | 1998 | 36 |
Why?
|
Mammaplasty | 1 | 2008 | 14 |
Why?
|
Surgical Flaps | 1 | 2008 | 51 |
Why?
|
Humans | 15 | 1987 | 1856 |
Why?
|
Costs and Cost Analysis | 2 | 1995 | 71 |
Why?
|
Middle Aged | 5 | 1995 | 1161 |
Why?
|
Lymphoma | 2 | 1994 | 96 |
Why?
|
Heart Valves | 1 | 2002 | 7 |
Why?
|
Bone Marrow Transplantation | 2 | 1994 | 90 |
Why?
|
Length of Stay | 1 | 2002 | 166 |
Why?
|
Female | 6 | 1987 | 1643 |
Why?
|
Aged | 3 | 1995 | 988 |
Why?
|
Antigen Presentation | 1 | 1999 | 28 |
Why?
|
Serum Amyloid A Protein | 1 | 1998 | 15 |
Why?
|
Receptors, Interleukin-2 | 1 | 1998 | 31 |
Why?
|
Lymphocyte Count | 1 | 1998 | 38 |
Why?
|
Blood Grouping and Crossmatching | 2 | 1995 | 14 |
Why?
|
Interleukin-10 | 1 | 1998 | 38 |
Why?
|
Interleukin-4 | 1 | 1998 | 62 |
Why?
|
Interleukin-2 | 1 | 1998 | 71 |
Why?
|
Male | 6 | 1976 | 1553 |
Why?
|
Hip Prosthesis | 1 | 1996 | 19 |
Why?
|
Erythrocyte Transfusion | 1 | 1996 | 29 |
Why?
|
Blood | 1 | 1996 | 67 |
Why?
|
Bone Marrow Purging | 1 | 1995 | 5 |
Why?
|
Coombs' Test | 1 | 1995 | 14 |
Why?
|
Insemination, Artificial, Homologous | 1 | 1995 | 6 |
Why?
|
Rh-Hr Blood-Group System | 1 | 1995 | 12 |
Why?
|
Antigens, Human Platelet | 1 | 1994 | 7 |
Why?
|
Plateletpheresis | 1 | 1994 | 5 |
Why?
|
Isoantibodies | 1 | 1994 | 25 |
Why?
|
Fetal Blood | 1 | 1995 | 54 |
Why?
|
Infection | 1 | 1994 | 57 |
Why?
|
HLA Antigens | 1 | 1994 | 38 |
Why?
|
Leukemia | 1 | 1995 | 70 |
Why?
|
Immunization | 1 | 1994 | 85 |
Why?
|
Retrospective Studies | 2 | 2008 | 653 |
Why?
|
Cell Survival | 1 | 1994 | 229 |
Why?
|
Immunoglobulin G | 1 | 1995 | 191 |
Why?
|
Immune Tolerance | 2 | 1987 | 72 |
Why?
|
Aged, 80 and over | 1 | 1998 | 599 |
Why?
|
Pulmonary Circulation | 1 | 2010 | 42 |
Why?
|
Treatment Outcome | 1 | 1998 | 661 |
Why?
|
Infant, Newborn | 1 | 1995 | 389 |
Why?
|
Citric Acid | 1 | 1988 | 18 |
Why?
|
Blood Coagulation Disorders | 1 | 1988 | 18 |
Why?
|
Adult | 4 | 1988 | 1317 |
Why?
|
Incidence | 1 | 2010 | 336 |
Why?
|
Neuromuscular Diseases | 1 | 1988 | 26 |
Why?
|
Splenic Diseases | 1 | 1987 | 13 |
Why?
|
Abscess | 1 | 1987 | 40 |
Why?
|
Heart Diseases | 1 | 1988 | 92 |
Why?
|
Bacterial Infections | 1 | 1987 | 88 |
Why?
|
Cross-Sectional Studies | 1 | 2008 | 253 |
Why?
|
Time Factors | 1 | 2010 | 896 |
Why?
|
Calcium | 1 | 1988 | 208 |
Why?
|
Risk Factors | 1 | 2008 | 555 |
Why?
|
Oligomycins | 1 | 1976 | 9 |
Why?
|
Hospital Charges | 1 | 1996 | 12 |
Why?
|
Graft Enhancement, Immunologic | 1 | 1996 | 2 |
Why?
|
Mitochondria, Liver | 1 | 1976 | 26 |
Why?
|
Adoptive Transfer | 1 | 1996 | 16 |
Why?
|
Transplantation Immunology | 1 | 1996 | 19 |
Why?
|
Isoantigens | 1 | 1996 | 18 |
Why?
|
Lymphocyte Subsets | 1 | 1996 | 26 |
Why?
|
Adenosine Triphosphatases | 1 | 1976 | 43 |
Why?
|
Mice, Inbred Strains | 1 | 1996 | 118 |
Why?
|
Linear Models | 1 | 1996 | 151 |
Why?
|
Histocompatibility | 1 | 1994 | 15 |
Why?
|
Forecasting | 1 | 1996 | 147 |
Why?
|
Cost-Benefit Analysis | 1 | 1996 | 118 |
Why?
|
Health Care Costs | 1 | 1996 | 73 |
Why?
|
Neoplasm Metastasis | 1 | 1996 | 112 |
Why?
|
Remission Induction | 1 | 1995 | 64 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 178 |
Why?
|
Transplantation, Autologous | 1 | 1994 | 78 |
Why?
|
Analysis of Variance | 1 | 1996 | 339 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1996 | 118 |
Why?
|
Proteins | 1 | 1976 | 192 |
Why?
|
Acute Disease | 1 | 1995 | 271 |
Why?
|
Cohort Studies | 1 | 1996 | 332 |
Why?
|
Survival Analysis | 1 | 1994 | 205 |
Why?
|
Lactobacillus | 1 | 1987 | 12 |
Why?
|
United States | 1 | 1996 | 604 |
Why?
|
Mice | 1 | 1996 | 623 |
Why?
|
Tomography, X-Ray Computed | 1 | 1987 | 321 |
Why?
|
Animals | 2 | 1976 | 1031 |
Why?
|
Membranes | 1 | 1976 | 23 |
Why?
|
Molecular Weight | 1 | 1976 | 154 |
Why?
|
Amino Acids | 1 | 1976 | 108 |
Why?
|
Protein Binding | 1 | 1976 | 256 |
Why?
|
Rats | 1 | 1976 | 530 |
Why?
|
